Product Information
BANZEL 40 MG/ML SUSPENSION is a brand product labeled by Eisai Inc., priced at $3.6486 per ML under NDC 62856058446. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 3, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the rufinamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/mL
Manufacturer
Eisai Inc.NDC
62856058446
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RUFINAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA201367FDA Approved
3/3/2011
TE Code
AB
On Market Since
3/3/2011
Price Statistics
The NADAC for BANZEL 40 MG/ML SUSPENSION has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 153.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6486 per ML |
|---|---|
| All-time high | $3.7207 (Feb 15, 2023) |
| All-time low | $1.4378 (Nov 28, 2013) |
| 52-week high | $3.6567 |
| 52-week low | $3.6452 |
| Median price | $3.5103 |
| Average price | $3.0967 |
| Largest weekly change | +10.0% (Aug 20, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the rufinamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BANZEL 40 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for BANZEL 40 MG/ML SUSPENSION, manufactured by Eisai Inc., is $3.6486 per ML (NDC 62856058446), effective Aug 19, 2026.
How has the price of BANZEL 40 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for BANZEL 40 MG/ML SUSPENSION has risen 153.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BANZEL 40 MG/ML SUSPENSION?
Since Nov 28, 2013, the NADAC for BANZEL 40 MG/ML SUSPENSION has ranged from a low of $1.4378 (Nov 28, 2013) to a high of $3.7207 (Feb 15, 2023), with a median of $3.5103 per ML.
Are there cheaper alternatives to BANZEL 40 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of BANZEL 40 MG/ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BANZEL 40 MG/ML SUSPENSION?
BANZEL 40 MG/ML SUSPENSION (NDC 62856058446) is labeled by Eisai Inc., and CMS classifies it as a brand product.